CVRx Appoints New Director, Adjusts Executive Compensation
Ticker: CVRX · Form: 8-K · Filed: Sep 3, 2024 · CIK: 1235912
| Field | Detail |
|---|---|
| Company | Cvrx, Inc. (CVRX) |
| Form Type | 8-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: CVRX
TL;DR
CVRx adds a new director and revises exec pay, effective Aug 27.
AI Summary
CVRx, Inc. announced on August 27, 2024, changes in its board of directors and executive compensation. Specifically, Dr. Robert L. Smith was appointed as a new director, and the company also entered into new employment agreements with certain executive officers, including a new Chief Medical Officer, Dr. David E. Pearlstone. These changes are effective as of August 27, 2024.
Why It Matters
The appointment of a new director and adjustments to executive compensation can signal strategic shifts or confidence in the company's future direction.
Risk Assessment
Risk Level: low — The filing primarily concerns board and executive changes, which are routine corporate governance matters.
Key Players & Entities
- CVRx, Inc. (company) — Registrant
- Dr. Robert L. Smith (person) — Newly appointed director
- Dr. David E. Pearlstone (person) — Newly appointed Chief Medical Officer
- August 27, 2024 (date) — Effective date of changes
FAQ
Who was appointed as a new director to CVRx, Inc.'s board?
Dr. Robert L. Smith was appointed as a new director to CVRx, Inc.'s board.
What is the effective date of the reported changes?
The earliest event reported is dated August 27, 2024, which is the effective date for the changes.
What other significant executive change was reported?
The company entered into new employment agreements with certain executive officers, including the appointment of Dr. David E. Pearlstone as Chief Medical Officer.
What type of filing is this for CVRx, Inc.?
This is a Form 8-K filing, reporting current events.
In which state is CVRx, Inc. incorporated?
CVRx, Inc. is incorporated in Delaware.
Filing Stats: 564 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-09-03 08:35:20
Key Financial Figures
- $0.01 — ich registered Common stock, par value $0.01 per share CVRX The Nasdaq Global S
Filing Documents
- tm2423147d1_8k.htm (8-K) — 25KB
- 0001104659-24-096051.txt ( ) — 195KB
- cvrx-20240827.xsd (EX-101.SCH) — 3KB
- cvrx-20240827_lab.xml (EX-101.LAB) — 33KB
- cvrx-20240827_pre.xml (EX-101.PRE) — 22KB
- tm2423147d1_8k_htm.xml (XML) — 4KB
02. Departure of
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 30, 2024, the Board of Directors (the "Board") of CVRx, Inc. (the "Company") appointed Kevin Ballinger and Mitch Hill as directors, effective September 3, 2024. Messrs. Ballinger and Hill will serve as Class I directors with terms expiring at the 2025 annual meeting of stockholders. The Board determined that Messrs. Ballinger and Hill qualify as independent directors pursuant to the listing standards of the Nasdaq Stock Market. Mr. Ballinger was appointed to serve on the Board's Nominating and Corporate Governance Committee and Mr. Hill was appointed to serve on the Board's Audit Committee and Compensation Committee. Messrs. Ballinger and Hill will receive compensation for their service in accordance with the non-employee director compensation program described under "Director compensation" set forth in the Company's proxy statement for its 2024 annual meeting of stockholders. On August 27, 2024, Ali Behbahani gave notice of his intention to resign from the Board effective at the close of business on September 2, 2024. In connection with Mr. Behbahani's resignation and the two new director appointments, the Board increased the number of directors constituting the Board to seven, effective September 3, 2024.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVRx, Inc. Date: September 3, 2024 By: /s/ Jared Oasheim Name: Jared Oasheim Its: Chief Financial Officer